NEWS AND EVENTS

Procaps Group Acquires 1st U.S.-Based Softgel Production Facility under the name Sofgen Pharmaceutic

Procaps Group Acquires 1st U.S.-Based Softgel Production Facility under the name Sofgen Pharmaceuticals!

As a leading pharmaceutical group, Procaps is focused on the expansion of its iCDMO business, offering integrated, end-to-end solutions in innovative dosage forms from development across delivery to the pharmaceutical and nutraceutical industries. 
 
Softigel has been known for its Softgel expertise and capabilities, now focused on LATAM and Southeast Asian markets. Softcaps, located in Brazil, offers manufacturing and development services to companies within MERCOSUR and South African markets, while Funtrition, a leading manufacturer and developer of nutritional gummy technologies, offers its products and services for big supplement players around the globe. 
 
With the acquisition of this new facility located in West Palm Beach, Florida, our Sofgen business provides the opportunity to deliver a wider product array in our innovative softgel technologies for companies interested in launching new products within North America and other Highly regulated markets.

For more information on our new site, capabilities, and explore new opportunities for your markets contact us at: communications@sofgenpharma.com

Coming soon our renovated site:
www.sofgenpharma.com 
 

Related News